Antibody & Protein Therapeutics Summit
Venue: Royal Sonesta Harbor Court Baltimore, Baltimore, MD, USA
Date: July 10 - 12, 2017

5th Protein Expression, Purification & Characterization

5th Protein-Protein Interaction

3rd Antibody Drug Conjugates

GTCbio offers comprehensive sponsorship packages for all our meetings, including presentation opportunities, exhibit and booth space, as well as the event delegate list. All our packages can be customized to meet your company's budget. For information, please contact us.
GTCbio encourages attendees to showcase their research at the conference by presenting a poster. The top 2-3 submitted posters will also be selected to give short oral presentations as part of the meeting program. Slots fill up quickly so submit yours online ASAP!

Dear Colleague,

We invite you to attend the Antibody & Protein Therapeutics Summit to be held on July 10-12, 2017 in Baltimore, MD. The Protein Therapeutics Summit is the ideal venue to network with your fellow researchers, providing access to over 125 presentations from leading industrial and academic experts and will feature research findings, case studies, and technology advancements.

This summit will discuss various areas in the field of protein science. New updates will be given in areas such as protein-protein interactions in drug designs, advances in antibody drug conjugates, bispecific and multispecific antibodies, the expression of difficult proteins, and the purification and characterization of proteins. Don't miss important insights on how to overcome the many hurdles that are associated with the production of proteins.

The Protein Therapeutics Summit will answer exciting key questions for the successful development of new drugs and targeted kinase signaling. Join this multi-disciplinary forum and network with colleagues from industry and academia to discuss the methods and tools that will ensure the most efficient and accurate optimization of proteins.

We hope to see you there!

Best regards,

The 2017 Advisory Committee

2017 Program Director
Victor-Jeffrey Leyton, Université de Sherbrooke
2017 Advisory Board Members
Neeraj Agrawal, Amgen
Ahuva Nissim, Queen Mary University
Amandeep Gakhal, Sutro Biopharma
Ann White, University of Southampton
Bill Harriman , Crystal Bioscience
Birgit Schoeberl, Merrimack Pharmaceuticals
Elad Firnberg, Revolve Biotechnologies
Ernesto Freire, Johns Hopkins University
Nicolas Fischer, Novimmune SA
Gregory Adams, Eleven Biotherapeutics
Janos Luka, Walter Reed Army Institute of Research
Matthew Robinson, Immunome, Inc
Michael R. Dyson, IONTAS Ltd
Andreas Pahl, Heidelberg Pharma
Pedro Berraondo López, CIMA, University of Navarra
Darren Schofield, MedImmune
Seema Kumar, EMD Serono
Jamshid Tanha, University of Ottawa
Thomas Pillow, Genentech
Medha J. Tomlinson, Abbvie
Yan Chen, Genentech

Platinum Sponsors

Media Partners